Transitional Coverage for Emerging Technologies

The Centers for Medicare & Medicaid Services (CMS) recently introduced the Transitional Coverage for Emerging Technologies (TCET) pathway, a voluntary expedited Medicare coverage process for certain FDA-designated Breakthrough Devices. This new pathway aims to support innovation while ensuring faster and more consistent access to emerging medical technologies for Medicare beneficiaries. The TCET pathway offers manufacturers increased pre-market engagement with CMS and a high level of flexibility to address evidence gaps for coverage. This initiative seeks to develop reliable evidence for informed healthcare decision-making and to ensure high-quality care for Medicare beneficiaries.